Therapeutic Potential Of Dietary Phase 2 Enzyme Inducers In Ameliorating Diseases That Have An Underlying Inflammatory Component

Therapeutic Potential Of Dietary Phase 2 Enzyme Inducers In Ameliorating Diseases That Have An Underlying Inflammatory Component2018-01-17T17:00:25-05:00

Pathogenesis of multiple sclerosis: an update on immunology

Pathogenesis of multiple sclerosis: an update on immunology2018-01-17T17:00:25-05:00

Cytosolic Phospholipase A2 Plays a Key Role in the Pathogenesis of Multiple Sclerosis-like Disease

Cytosolic Phospholipase A2 Plays a Key Role in the Pathogenesis of Multiple Sclerosis-like Disease2018-01-17T17:00:21-05:00

Anti-myelin oligodendrocyte glycoprotein antibodies in multiple sclerosis

Anti-myelin oligodendrocyte glycoprotein antibodies in multiple sclerosis2018-01-17T16:59:56-05:00

Innate Immunity in Multiple Sclerosis: Myeloid Dendritic Cells in Secondary Progressive Multiple Sclerosis Are Activated and Drive a Proinflammatory Immune Response

Innate Immunity in Multiple Sclerosis: Myeloid Dendritic Cells in Secondary Progressive Multiple Sclerosis Are Activated and Drive a Proinflammatory Immune Response2018-01-17T16:59:56-05:00

Immunological Memory: Contribution of Memory B Cells Expressing Costimulatory Molecules in the Resting State

Immunological Memory: Contribution of Memory B Cells Expressing Costimulatory Molecules in the Resting State2018-01-17T16:59:49-05:00

Vasoactive intestinal peptide induces regulatory dendritic cells with therapeutic effects on autoimmune disorders

Vasoactive intestinal peptide induces regulatory dendritic cells with therapeutic effects on autoimmune disorders2018-01-17T16:59:42-05:00

Pathogenesis of multiple sclerosis

Pathogenesis of multiple sclerosis2018-01-17T16:59:42-05:00

IL-6 induces regionally selective spinal cord injury in patients with the neuroinflammatory disorder transverse myelitis

IL-6 induces regionally selective spinal cord injury in patients with the neuroinflammatory disorder transverse myelitis2018-01-17T16:59:38-05:00

Cutting Edge: CD4+ CD25+ Regulatory T Cells Suppress Antigen-Specific Autoreactive Immune Responses and Central Nervous System Inflammation During Active Experimental Autoimmune Encephalomyelitis

Cutting Edge: CD4+ CD25+ Regulatory T Cells Suppress Antigen-Specific Autoreactive Immune Responses and Central Nervous System Inflammation During Active Experimental Autoimmune Encephalomyelitis2018-01-17T16:59:38-05:00